Home › Endometriumkanker › District of Columbia › Washington
Endometriumkanker klinische studies in Washington, DC
18 studies voor Endometriumkanker zoeken deelnemers op locaties in en rond Washington (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RekruterenFase 3
- MedStar Washington Hospital Center, Washington D.C.
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruterenFase 2
- Walter Reed National Military Medical Center, Bethesda · 7 mijl verwijderd
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
RekruterenFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruterenFase 1
- Georgetown University Medical Center, Washington D.C.
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
RekruterenFase 3
- MedStar Washington Hospital Center, Washington D.C.
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
RekruterenFase 3
- MedStar Washington Hospital Center ( Site 5005), Washington D.C.
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RekruterenFase 3
- MedStar Washington Hospital, Washington D.C.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RekruterenFase 3
- Research Site, Silver Spring · 7 mijl verwijderd
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RekruterenFase 1
- Georgetown University Medical Center, Washington D.C.
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruterenFase 1/2
- Children's National Medical Center, Washington D.C.
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekruterenFase 1
- Normunity Investigational Site, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- National Institutes of Health, Bethesda · 7 mijl verwijderd
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RekruterenFase 3
- Research Site, Washington D.C.
- Research Site, Silver Spring · 7 mijl verwijderd
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
RekruterenFase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mijl verwijderd
- Massive Bio SYNERGY-AI site, Bethesda · 7 mijl verwijderd
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
RekruterenFase 1
- Holy Cross Hospital, Silver Spring · 7 mijl verwijderd
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
RekruterenFase 2/3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mijl verwijderd
Endometriumkanker studies in andere steden
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Columbus, OH25 studies
- Chicago, IL25 studies
- Oklahoma City, OK25 studies
Andere studies in Washington
- Kanker (alle vormen)58 studies
- Niet-kleincellige longkanker55 studies
- Borstkanker46 studies
- Metastatische kanker43 studies
- Longkanker41 studies
- Prostaatkanker38 studies
- Obesitas33 studies
- Colorectale kanker29 studies
- Cardiovasculaire ziekte28 studies
- Blasenkanker26 studies
- Acute myeloïde leukemie24 studies
- Eierstokkanker23 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.